PMS38
TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS
WITH MODERATE TO SEVERE ACTIVE PSORIATIC
ARTHRITIS INTOLERANT OR WITH THERAPEUTIC
FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE-
MODIFYING DRUGS
PMS38
TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS
WITH MODERATE TO SEVERE ACTIVE PSORIATIC
ARTHRITIS INTOLERANT OR WITH THERAPEUTIC
FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE-
MODIFYING DRUGS
Data
2020
Autores
Costa, MGS
Santos, M
Journal Title
Journal ISSN
Volume Title
Publisher
VALUE IN HEALTH
Resumo
Description
Palavras-chave
Citação
Costa MGS, Santos M. TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ACTIVE PSORIATIC ARTHRITIS INTOLERANT OR WITH THERAPEUTIC FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE- MODIFYING DRUGS. VALUE IN HEALTH. 2020. doi: 10.1016/j.jval.2020.08.1169